Curaleaf Holdings Inc

Curaleaf Holdings plans a U.S. exchange uplisting and a 1:3 reverse split to boost liquidity and meet exchange requirements, positioning the cannabis company for growth.

Curaleaf leads the largest medical‑cannabis patient survey, revealing real‑world benefits for anxiety, depression and PTSD—offering hope and evidence for mental‑health treatment.

Curaleaf Holdings joins the 38th ROTH Conference, showcasing leadership, stakeholder engagement and growth strategy in the cannabis market.

Curaleaf Holdings faces steep volatility and negative earnings amid a booming global cannabis market; discover why investors should watch its turnaround strategy closely.

Curaleaf’s bold restructuring—bundling a special meeting with its AGM—aims to keep its Canadian roots while gaining Delaware’s legal flexibility, a move that could reshape investor sentiment and the company’s future in a volatile cannabis market.

Curaleaf launches adult‑use sales in Maine, boosting market reach despite a negative P/E and volatile stock, showing investor optimism amid cannabis industry growth.

Curaleaf Holdings Inc. set to release 2025 earnings, promising insights on growth, margins, and cash flow amid Canada’s stable policy outlook and cannabis‑sector optimism.

Curaleaf Holdings’ latest market moves reveal how it’s tackling cannabis industry volatility—leveraging a broad dispensary network, supply‑chain upgrades, and innovation to boost growth.

Curaleaf Holdings, a leading US cannabis distributor, has secured a $100 million revolving credit facility from Needham Bank, providing the company with increased liquidity and flexibility to support expansion, acquisitions, and capital expenditures.

Curaleaf Holdings Inc. saw its stock price surge by over 15% on August 4, 2025, driven by positive industry developments and research from the American Medical Association.